Right to Documentation. Upon request, BDSI shall have the right to request reasonable documentation of ACCENTIA’s calculations to determine ACCENTIA’s Net Sales, Sublicensee Revenues and/or Sublicensee Net Sales for the Licensed Products and to request discussion of such calculations with appropriate representatives of ACCENTIA. BDSI shall make all reasonable efforts to provide to ACCENTIA any existing data or other information owned by BDSI to support ACCENTIA’s efforts to obtain FDA approval.
Appears in 4 contracts
Samples: License Agreement (Accentia Biopharmaceuticals Inc), License Agreement (Accentia Biopharmaceuticals Inc), License Agreement (Accentia Biopharmaceuticals Inc)